Active	Status	Sponsor type	Region	Phase	Filter
3 Active 3 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Parhofer, Klaus G
MultiSELECt, NCT02791802: Effect of Lipoprotein(a) Elimination by Lipoprotein Apheresis on Cardiovascular Outcomes	Recruiting	N/A	1000	Europe		Technische Universität Dresden, Kaneka Pharma Europe N.V.	Lipoprotein Types--Lp System Lp(A) Hyperlipoproteinemia	12/22	12/22
NCT04210206: Short-term Effects of Good Metabolic Control on Cognitive Function, Wellbeing, and Metabolic Parameters in Adult Patients With Phenylketonuria	Terminated	N/A	13	Europe	PHE-diet	Klaus Parhofer	Phenylketonurias	08/23	08/23
PERI-DYS, NCT03110432: Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry	Active, not recruiting	N/A	1713	Europe	PCSK9 Inhibitor [EPC], Repatha, Praluent, Standard lipid lowering therapy, Statins, ezetimibe, nicotinic acid, fibrates, cholestagel, omega-3 fatty acids	GWT-TUD GmbH	Dyslipoproteinemias	03/24	06/24